APA (7th ed.) Citation

R, M., R, B., & A, K. (2021). Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway. Metabolic brain disease, 36(7), 1833. https://doi.org/10.1007/s11011-021-00811-7

Chicago Style (17th ed.) Citation

R, Mehta, Bhandari R, and Kuhad A. "Exploring Nordihydroguaretic Acid (NDGA) as a Plausible Neurotherapeutic in the Experimental Paradigm of Autism Spectrum Disorders Targeting Nitric Oxide Pathway." Metabolic Brain Disease 36, no. 7 (2021): 1833. https://doi.org/10.1007/s11011-021-00811-7.

MLA (9th ed.) Citation

R, Mehta, et al. "Exploring Nordihydroguaretic Acid (NDGA) as a Plausible Neurotherapeutic in the Experimental Paradigm of Autism Spectrum Disorders Targeting Nitric Oxide Pathway." Metabolic Brain Disease, vol. 36, no. 7, 2021, p. 1833, https://doi.org/10.1007/s11011-021-00811-7.